Ceribell Inc. (Ticker: CBLL) is a commercial-stage medical technology company focused on diagnosing and managing serious neurological conditions, particularly seizures. The company developed the Ceribell System, an EEG platform that combines portable hardware with AI-powered algorithms to provide rapid, point-of-care diagnosis and continuous monitoring of patients at risk of seizures in acute care settings. As of June 30, 2024, the Ceribell System has been used in over 100,000 patients across 450 healthcare facilities.

Ceribell will list on October 11, 2024, on NASDAQ. The company is offering 6.7 million shares at a price range of $14.00 to $16.00, with a total offer size of approximately $100.5 million. The expected market capitalization at the offer is $451.69 million. The offering is managed by BofA Securities and J.P. Morgan, with co-managers William Blair, TD Cowen, and Canaccord Genuity.